Alligator Bioscience’s mitazalimab gets FDA approval for clinical trials in US

pharmanewsdaily- December 6, 2020 0

Swedish biotech company Alligator Bioscience has announced that the US Food and Drug Administration (FDA) has approved its investigational new drug (IND) application for mitazalimab, ... Read More